High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study. (Q51782027)
Jump to navigation
Jump to search
scientific article published on 30 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study. |
scientific article published on 30 May 2017 |
Statements
1 reference
High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study. (English)
1 reference
Östen Ljunggren
1 reference
Per-Anton Westerberg
1 reference
Gunnar Sterner
1 reference
Elin Isaksson
1 reference
Fjölnir Elvarson
1 reference
Hamid Dezfoolian
1 reference
Torbjörn Linde
1 reference
1 March 2018
1 reference
33
1 reference
466-471
1 reference
3
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference